The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2
Authors
Simone Ardern-Holmes
Sydney Children’s Hospital, Westmead, Sydney, Australia
Cassandra White
cassandra.white1@health.nsw.gov.au
Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Sydney, Australia
Sarita Bahure
Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Sydney, Australia
Simon So
Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Sydney, Australia
Geoff McCowage
Sydney Children’s Hospital, Westmead, Sydney, Australia
Elizabeth Hovey
NHMRC CTC University of Sydney, Westmead, Sydney, Australia
Simon Troon
Hollywood Private Hospital, Perth, Western Australia, Australia
Paul De Souza
NHMRC CTC University of Sydney, Westmead, Sydney, Australia
John Simes
NHMRC CTC University of Sydney, Westmead, Sydney, Australia
Michael Slancar
Bond University, Queensland, Australia
Mark Dexter
Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Sydney, Australia
Mark Wong
Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Sydney, Australia
Language: English
Page range: 5 - 14
Published on: May 1, 2021
Published by: Australasian Neuroscience Nurses Association
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2021 Simone Ardern-Holmes, Cassandra White, Sarita Bahure, Simon So, Geoff McCowage, Elizabeth Hovey, Simon Troon, Paul De Souza, John Simes, Michael Slancar, Mark Dexter, Mark Wong, published by Australasian Neuroscience Nurses Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.